Fact CheckerSign in

NCT07074093Enrolling by invitation

Effect of an App-based Intervention on Air Pollution in COPD Patients

Effect of an Educational Intervention and an App-based Outdoor Air Pollution Alert System on Reducing Exacerbations in COPD Patients

Source: ClinicalTrials.gov · Last updated 20 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study will test whether a combination of health education, a mobile app, and a smart band can help people with chronic obstructive pulmonary disease (COPD) improve their quality of life and reduce flare-ups. Participants will be randomly assigned to one of two groups: One group will receive health education, use a mobile app that shows real-time air quality (AirVisual), and wear a smart band that tracks activity and sleep (Amazfit Band 5). The other group will receive standard care and advice. All participants will complete health checks and quality-of-life questionnaires at the beginning of the study and again after 6 months. The goal is to find out if this combination of tools helps people with COPD manage their condition better and have fewer flare-ups.

Status (registry)
Enrolling by invitation
Study type
Interventional
Enrollment
150 (estimated)
First submitted
8 Jul 2025
Start date
16 Jun 2025
Primary completion date
Jun 2026
Lead sponsor
Fundacion para la Investigacion y Formacion en Ciencias de la Salud
Diseases
COPD
NCT number
NCT07074093

What you commit to

  • Study type: Interventional
  • Planned participants: 150
  • From 16 Jun 2025 to the primary completion date, Jun 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Diagnosis of a respiratory disease other than COPD (e.g., asthma, interstitial lung disease)
  • Moderate to severe cognitive impairment
  • Significant physical limitation that prevents participation in physical activity (e.g., NYHA Class III or IV heart failure, musculoskeletal conditions limiting walking)
  • Advanced kidney or liver disease
  • Severe mental illness or terminal condition

Other

  • Participation in another clinical trial
  • Inability to use the mobile phone or smart band due to physical or technological limitations
  • Plans to relocate to another city within 12 months of study start

Who the study is looking for

  • Male or female, aged 18 years or older
  • Clinical diagnosis of chronic obstructive pulmonary disease (COPD) based on GOLD 2022 criteria (post-bronchodilator FEV1/FVC \< 0.70)
  • Receiving care at urban primary care centers in Salamanca, Spain
  • Able to use a smartphone (independently or with minimal assistance)
  • Able and willing to provide written informed consent

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Unidad de Investigación de AP de Salamanca
Coordinator of this site? Confirm its status
SalamancaSpainUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.